Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targets for therapy in sarcomeric cardiomyopathies.

Cardiovascular research - 1 Apr 2015

Tardiff Jil C, Carrier Lucie, Bers Donald M, Poggesi Corrado, Ferrantini Cecilia, Coppini Raffaele, Maier Lars S, Ashrafian Houman, Huke Sabine, van der Velden Jolanda

Abstract excerpt

To date, no compounds or interventions exist that treat or prevent sarcomeric cardiomyopathies. Established therapies currently improve the outcome, but novel therapies may be able to more fundamentally affect the disease process and course. Investigations of the pathomechanisms are generating molecular insights that can be useful for the design of novel specific drugs suitable for clinical use. As perturbations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathies
Share to Cardiovascular Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Energy Metabolism

Share to Genetic Markers

Share to Genetic Therapy

Share to Molecular Targeted Therapy

Share to Sarcomeres

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 25634554
DOI: 10.1093/cvr/cvv023
PMCID: PMC4402369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targets for therapy in sarcomeric cardiomyopathies.PMID 25634554Read ↗

Novel Therapies for Prevention and Early Treatment of CardiomyopathiesSemantic proximity Read ↗

Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies.Semantic proximity Read ↗

Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Semantic proximity Read ↗

Research priorities in sarcomeric cardiomyopathies.Semantic proximity Read ↗

Preventative therapeutic approaches for hypertrophic cardiomyopathy.Semantic proximity Read ↗

Translation of New and Emerging Therapies for Genetic CardiomyopathiesSemantic proximity Read ↗

A straightforward guide to the sarcomeric basis of cardiomyopathies.Semantic proximity Read ↗

Targeting the sarcomere in inherited cardiomyopathies.Semantic proximity Read ↗

Direct Sarcomere Modulators Are Promising New Treatments for CardiomyopathiesSemantic proximity Read ↗

Therapeutic Strategies Targeting Inherited Cardiomyopathies.Semantic proximity Read ↗

Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives.Semantic proximity Read ↗

Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.